BMC Nephrology BioMed Central Open Access

First Page		Document Content
Date: 2011-08-15 22:01:49 Growth factors Hematology Iron metabolism Amgen Erythropoietin Sickle-cell disease Nephrology Darbepoetin alfa Hepcidin Medicine Biology Erythropoiesis-stimulating agents		BMC Nephrology BioMed Central Open Access Add to Reading List Source URL: www.aktn.org.au Download Document from Source Website File Size: 255,05 KB Share Document on Facebook

	Reprint from January 8, 2007 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINT DocID: 13F1b - View Document
	REPRINTED WITH PERMISSION Business Day DocID: 13gi3 - View Document
	Original Investigation A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylli DocID: YO7g - View Document
	BMC Nephrology BioMed Central Open Access DocID: XoWc - View Document
	STATISTICAL ANALYSIS PLAN (Version[removed]Protocol Title: A randomised, placebo-controlled trial of oxpentifylline on DocID: XouS - View Document